Oracle report due Thursday

Oracle Corp will report its first-quarter figures before the market opens on Thursday 18 September. The consensus is for a revenue of $8.87 billion and earnings per share of $0.65.

Oracle logo
Source: Bloomberg

The company is trading at the $40.62 level. The share price is down over 5% since the company reported its fourth-quarter figures in which revenue and EPS were $11.32 billion and $0.92 respectively, both missing estimates. Oracle’s share price hasn’t fully recovered from the fourth-quarter announcement; the stock spent most of the past three months trading close to $41.

The company is facing competition from smaller software firms like Salesforce.com Inc and Workday Inc. Added to that, the license fees for using software are no longer paid up front, they are paid on an ongoing basis.

Equity analysts are very bullish on Oracle. Out of the 44 recommendations, 26 are buys, 15 are holds and only three are sell ratings. The 200-day moving average is providing support at $39.46 and if results exceed estimates the stock could target $43.27.

Orcale Corp is available for extended-hours trading

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.